Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID^®) with Concomitant Medications in Real-World Clinical Settings

Background: This research article delves into the battle against the COVID-19 pandemic, focusing on the efficacy and, particularly, the safety of the combination of nirmatrelvir with ritonavir, which is found in the pharmaceutical product Paxlovid^®. This study aims to analyze...

Full description

Bibliographic Details

Published in:	Pathogens
Main Authors:	Petra Zatovkaňuková, Dalibor Veselý, Jiří Slíva
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Subjects:	COVID-19 drug interactions nirmatrelvir Paxlovid ritonavir
Online Access:	https://www.mdpi.com/2076-0817/13/12/1055